Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies.
Pepper AGS, Zucchetto A, Norris K, Tissino E, Polesel J, Soe Z, Allsup D, Hockaday A, Ow PL, Hillmen P, Rawstron A, Catovsky D, Bulian P, Bomben R, Baird DM, Fegan CD, Gattei V, Pepper C. Pepper AGS, et al. Among authors: baird dm. Leukemia. 2022 Jan;36(1):271-274. doi: 10.1038/s41375-021-01322-1. Epub 2021 Jun 19. Leukemia. 2022. PMID: 34148055 Free PMC article. No abstract available.
Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient.
Lin TT, Hewamana S, Ward R, Taylor H, Payne T, Pratt G, Baird D, Fegan C, Pepper C. Lin TT, et al. Br J Haematol. 2008 Aug;142(4):595-605. doi: 10.1111/j.1365-2141.2008.07236.x. Epub 2008 May 22. Br J Haematol. 2008. PMID: 18503580 Free article.
Shortened telomeres: a driving force behind leukemia?
Pepper C, Baird DM. Pepper C, et al. Among authors: baird dm. Future Oncol. 2010 Nov;6(11):1681-6. doi: 10.2217/fon.10.135. Future Oncol. 2010. PMID: 21142655 Free article. No abstract available.
Telomere dysfunction and its role in haematological cancer.
Jones CH, Pepper C, Baird DM. Jones CH, et al. Among authors: baird dm. Br J Haematol. 2012 Mar;156(5):573-87. doi: 10.1111/j.1365-2141.2011.09022.x. Epub 2012 Jan 11. Br J Haematol. 2012. PMID: 22233151 Free article. Review.
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease.
Lin TT, Norris K, Heppel NH, Pratt G, Allan JM, Allsup DJ, Bailey J, Cawkwell L, Hills R, Grimstead JW, Jones RE, Britt-Compton B, Fegan C, Baird DM, Pepper C. Lin TT, et al. Among authors: baird dm. Br J Haematol. 2014 Oct;167(2):214-23. doi: 10.1111/bjh.13023. Epub 2014 Jul 3. Br J Haematol. 2014. PMID: 24990087 Free article.
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
Strefford JC, Kadalayil L, Forster J, Rose-Zerilli MJ, Parker A, Lin TT, Heppel N, Norris K, Gardiner A, Davies Z, Gonzalez de Castro D, Else M, Steele AJ, Parker H, Stankovic T, Pepper C, Fegan C, Baird D, Collins A, Catovsky D, Oscier DG. Strefford JC, et al. Leukemia. 2015 Dec;29(12):2411-4. doi: 10.1038/leu.2015.217. Epub 2015 Aug 10. Leukemia. 2015. PMID: 26256637 Free PMC article. No abstract available.
108 results